Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wingfield

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Development of a novel, pan-variant aerosol intervention for COVID-19Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Plos One|July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizerRobert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Building social equity and person-centred innovation into the end TB responseN Engel, I Apolosi, A Bhargava, et al.
Nature Immunology|May 23, 2017
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiencyBehdad Afzali, Juha Grönholm, Jana Vandrovcova, et al.
The New England Journal of Medicine|July 17, 2014
Activated STING in a vascular and pulmonary syndromeY Liu, A A Jesus, B Marrero, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Development of a novel, pan-variant aerosol intervention for COVID-19Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Plos One|July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizerRobert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Building social equity and person-centred innovation into the end TB responseN Engel, I Apolosi, A Bhargava, et al.
Nature Immunology|May 23, 2017
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiencyBehdad Afzali, Juha Grönholm, Jana Vandrovcova, et al.
The New England Journal of Medicine|July 17, 2014
Activated STING in a vascular and pulmonary syndromeY Liu, A A Jesus, B Marrero, et al.
Pageof 19